Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial -
Etomidate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Complications
1 trial -
Evaluation of social, cultural and behavioral factors
International Peace Maternity and Child Health Hospital
Cardio-vascular Disease
1 trial -
Exclusive Enteral Nutrition Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Biotech Pharmaceutical Co.,
Cognitive Functions Perceptual Disturbances
1 trial -
Exparel block in arthroscopic shoulder surgery
Pacira Ireland Limited
Injury of Shoulder Region
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
FAST Technique
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ST-Segment Elevation Myocardial Infarction
1 trial -
FSD-F2R6-A-CP
Quantum Biopharma
Acute Alcohol Intoxication
1 trial -
Facility HIVST
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Fecal Microbiota Transplantation (FMT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 1 Diabetes
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
Fibre mixture
BRIGHT MINDS BIOSCIENCES INC.
Health Status
1 trial -
Fluoxetine
The University of Hong Kong
Depression
1 trial -
Fluoxetine
United Therapeutics Europe Ltd
Depression - Major Depressive Disorder
1 trial -
Fluoxetine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Folic acid
CRESCENT BIOPHARMA, INC.
Acute Myocardial Infarction
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
Fortified food rations
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Fruit Bar
United Therapeutics Europe Ltd
Bioavailability
1 trial -
G-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intrauterine Adhesion
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources